+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

HLA Typing for Transplant - Global Market Trajectory & Analytics

  • ID: 4805551
  • Report
  • April 2021
  • Region: Global
  • 218 pages
  • Global Industry Analysts, Inc
Global HLA Typing for Transplant Market to Reach $937.9 Million by 2027

Amid the COVID-19 crisis, the global market for HLA Typing for Transplant estimated at US$637.8 Million in the year 2020, is projected to reach a revised size of US$937.9 Million by 2027, growing at a CAGR of 5.7% over the period 2020-2027. Non-Molecular Assay, one of the segments analyzed in the report, is projected to record 5.1% CAGR and reach US$581.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Molecular Assay segment is readjusted to a revised 6.7% CAGR for the next 7-year period.



The U.S. Market is Estimated at $188 Million, While China is Forecast to Grow at 5.3% CAGR

The HLA Typing for Transplant market in the U.S. is estimated at US$188 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$165.6 Million by the year 2027 trailing a CAGR of 5.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.5% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Select Competitors (Total 41 Featured):
  • Abbott Laboratories
  • Affymetrix, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Immucor, Inc.
  • Luminex Corporation
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY
  • Influencer Market Insights
  • Impact of Covid-19 and a Looming Global Recession
  • Table 1: World Current & Future Analysis for HLA Typing for Transplant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for HLA Typing for Transplant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for HLA Typing for Transplant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • Table 4: World Current & Future Analysis for Non-Molecular Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Non-Molecular Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Non-Molecular Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 7: World Current & Future Analysis for Molecular Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for Molecular Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for Molecular Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 10: World Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 11: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 12: World 15-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 13: World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 14: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 15: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 16: World Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 17: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 18: World 15-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 19: World Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 20: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 21: World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 22: World Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 23: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 24: World 15-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
  • Table 25: USA Current & Future Analysis for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 26: USA Historic Review for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 27: USA 15-Year Perspective for HLA Typing for Transplant by Technology - Percentage Breakdown of Value Sales for Non-Molecular Assay and Molecular Assay for the Years 2012, 2020 & 2027
  • Table 28: USA Current & Future Analysis for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 29: USA Historic Review for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 30: USA 15-Year Perspective for HLA Typing for Transplant by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
  • Table 31: USA Current & Future Analysis for HLA Typing for Transplant by Application - Diagnostics and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: USA Historic Review for HLA Typing for Transplant by Application - Diagnostics and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 33: USA 15-Year Perspective for HLA Typing for Transplant by Application - Percentage Breakdown of Value Sales for Diagnostics and Research for the Years 2012, 2020 & 2027
  • Table 34: Canada Current & Future Analysis for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 35: Canada Historic Review for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 36: Canada 15-Year Perspective for HLA Typing for Transplant by Technology - Percentage Breakdown of Value Sales for Non-Molecular Assay and Molecular Assay for the Years 2012, 2020 & 2027
  • Table 37: Canada Current & Future Analysis for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 38: Canada Historic Review for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 39: Canada 15-Year Perspective for HLA Typing for Transplant by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
  • Table 40: Canada Current & Future Analysis for HLA Typing for Transplant by Application - Diagnostics and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 41: Canada Historic Review for HLA Typing for Transplant by Application - Diagnostics and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 42: Canada 15-Year Perspective for HLA Typing for Transplant by Application - Percentage Breakdown of Value Sales for Diagnostics and Research for the Years 2012, 2020 & 2027
  • Table 43: Japan Current & Future Analysis for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 44: Japan Historic Review for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 45: Japan 15-Year Perspective for HLA Typing for Transplant by Technology - Percentage Breakdown of Value Sales for Non-Molecular Assay and Molecular Assay for the Years 2012, 2020 & 2027
  • Table 46: Japan Current & Future Analysis for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 47: Japan Historic Review for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 48: Japan 15-Year Perspective for HLA Typing for Transplant by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
  • Table 49: Japan Current & Future Analysis for HLA Typing for Transplant by Application - Diagnostics and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 50: Japan Historic Review for HLA Typing for Transplant by Application - Diagnostics and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 51: Japan 15-Year Perspective for HLA Typing for Transplant by Application - Percentage Breakdown of Value Sales for Diagnostics and Research for the Years 2012, 2020 & 2027
  • Table 52: China Current & Future Analysis for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 53: China Historic Review for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 54: China 15-Year Perspective for HLA Typing for Transplant by Technology - Percentage Breakdown of Value Sales for Non-Molecular Assay and Molecular Assay for the Years 2012, 2020 & 2027
  • Table 55: China Current & Future Analysis for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 56: China Historic Review for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 57: China 15-Year Perspective for HLA Typing for Transplant by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
  • Table 58: China Current & Future Analysis for HLA Typing for Transplant by Application - Diagnostics and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 59: China Historic Review for HLA Typing for Transplant by Application - Diagnostics and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 60: China 15-Year Perspective for HLA Typing for Transplant by Application - Percentage Breakdown of Value Sales for Diagnostics and Research for the Years 2012, 2020 & 2027
  • Table 61: Europe Current & Future Analysis for HLA Typing for Transplant by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 62: Europe Historic Review for HLA Typing for Transplant by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 63: Europe 15-Year Perspective for HLA Typing for Transplant by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
  • Table 64: Europe Current & Future Analysis for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 65: Europe Historic Review for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 66: Europe 15-Year Perspective for HLA Typing for Transplant by Technology - Percentage Breakdown of Value Sales for Non-Molecular Assay and Molecular Assay for the Years 2012, 2020 & 2027
  • Table 67: Europe Current & Future Analysis for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 68: Europe Historic Review for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 69: Europe 15-Year Perspective for HLA Typing for Transplant by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
  • Table 70: Europe Current & Future Analysis for HLA Typing for Transplant by Application - Diagnostics and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 71: Europe Historic Review for HLA Typing for Transplant by Application - Diagnostics and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 72: Europe 15-Year Perspective for HLA Typing for Transplant by Application - Percentage Breakdown of Value Sales for Diagnostics and Research for the Years 2012, 2020 & 2027
  • Table 73: France Current & Future Analysis for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 74: France Historic Review for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 75: France 15-Year Perspective for HLA Typing for Transplant by Technology - Percentage Breakdown of Value Sales for Non-Molecular Assay and Molecular Assay for the Years 2012, 2020 & 2027
  • Table 76: France Current & Future Analysis for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 77: France Historic Review for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 78: France 15-Year Perspective for HLA Typing for Transplant by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
  • Table 79: France Current & Future Analysis for HLA Typing for Transplant by Application - Diagnostics and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 80: France Historic Review for HLA Typing for Transplant by Application - Diagnostics and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 81: France 15-Year Perspective for HLA Typing for Transplant by Application - Percentage Breakdown of Value Sales for Diagnostics and Research for the Years 2012, 2020 & 2027
  • Table 82: Germany Current & Future Analysis for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 83: Germany Historic Review for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 84: Germany 15-Year Perspective for HLA Typing for Transplant by Technology - Percentage Breakdown of Value Sales for Non-Molecular Assay and Molecular Assay for the Years 2012, 2020 & 2027
  • Table 85: Germany Current & Future Analysis for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 86: Germany Historic Review for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 87: Germany 15-Year Perspective for HLA Typing for Transplant by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
  • Table 88: Germany Current & Future Analysis for HLA Typing for Transplant by Application - Diagnostics and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 89: Germany Historic Review for HLA Typing for Transplant by Application - Diagnostics and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 90: Germany 15-Year Perspective for HLA Typing for Transplant by Application - Percentage Breakdown of Value Sales for Diagnostics and Research for the Years 2012, 2020 & 2027
  • Table 91: Italy Current & Future Analysis for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 92: Italy Historic Review for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 93: Italy 15-Year Perspective for HLA Typing for Transplant by Technology - Percentage Breakdown of Value Sales for Non-Molecular Assay and Molecular Assay for the Years 2012, 2020 & 2027
  • Table 94: Italy Current & Future Analysis for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 95: Italy Historic Review for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 96: Italy 15-Year Perspective for HLA Typing for Transplant by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
  • Table 97: Italy Current & Future Analysis for HLA Typing for Transplant by Application - Diagnostics and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 98: Italy Historic Review for HLA Typing for Transplant by Application - Diagnostics and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 99: Italy 15-Year Perspective for HLA Typing for Transplant by Application - Percentage Breakdown of Value Sales for Diagnostics and Research for the Years 2012, 2020 & 2027
  • Table 100: UK Current & Future Analysis for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 101: UK Historic Review for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 102: UK 15-Year Perspective for HLA Typing for Transplant by Technology - Percentage Breakdown of Value Sales for Non-Molecular Assay and Molecular Assay for the Years 2012, 2020 & 2027
  • Table 103: UK Current & Future Analysis for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 104: UK Historic Review for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 105: UK 15-Year Perspective for HLA Typing for Transplant by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
  • Table 106: UK Current & Future Analysis for HLA Typing for Transplant by Application - Diagnostics and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 107: UK Historic Review for HLA Typing for Transplant by Application - Diagnostics and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 108: UK 15-Year Perspective for HLA Typing for Transplant by Application - Percentage Breakdown of Value Sales for Diagnostics and Research for the Years 2012, 2020 & 2027
  • Table 109: Rest of Europe Current & Future Analysis for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 110: Rest of Europe Historic Review for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 111: Rest of Europe 15-Year Perspective for HLA Typing for Transplant by Technology - Percentage Breakdown of Value Sales for Non-Molecular Assay and Molecular Assay for the Years 2012, 2020 & 2027
  • Table 112: Rest of Europe Current & Future Analysis for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 113: Rest of Europe Historic Review for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 114: Rest of Europe 15-Year Perspective for HLA Typing for Transplant by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
  • Table 115: Rest of Europe Current & Future Analysis for HLA Typing for Transplant by Application - Diagnostics and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 116: Rest of Europe Historic Review for HLA Typing for Transplant by Application - Diagnostics and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 117: Rest of Europe 15-Year Perspective for HLA Typing for Transplant by Application - Percentage Breakdown of Value Sales for Diagnostics and Research for the Years 2012, 2020 & 2027
  • Table 118: Asia-Pacific Current & Future Analysis for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 119: Asia-Pacific Historic Review for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 120: Asia-Pacific 15-Year Perspective for HLA Typing for Transplant by Technology - Percentage Breakdown of Value Sales for Non-Molecular Assay and Molecular Assay for the Years 2012, 2020 & 2027
  • Table 121: Asia-Pacific Current & Future Analysis for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 122: Asia-Pacific Historic Review for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 123: Asia-Pacific 15-Year Perspective for HLA Typing for Transplant by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
  • Table 124: Asia-Pacific Current & Future Analysis for HLA Typing for Transplant by Application - Diagnostics and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 125: Asia-Pacific Historic Review for HLA Typing for Transplant by Application - Diagnostics and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 126: Asia-Pacific 15-Year Perspective for HLA Typing for Transplant by Application - Percentage Breakdown of Value Sales for Diagnostics and Research for the Years 2012, 2020 & 2027
  • Table 127: Rest of World Current & Future Analysis for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 128: Rest of World Historic Review for HLA Typing for Transplant by Technology - Non-Molecular Assay and Molecular Assay Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 129: Rest of World 15-Year Perspective for HLA Typing for Transplant by Technology - Percentage Breakdown of Value Sales for Non-Molecular Assay and Molecular Assay for the Years 2012, 2020 & 2027
  • Table 130: Rest of World Current & Future Analysis for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 131: Rest of World Historic Review for HLA Typing for Transplant by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 132: Rest of World 15-Year Perspective for HLA Typing for Transplant by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
  • Table 133: Rest of World Current & Future Analysis for HLA Typing for Transplant by Application - Diagnostics and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 134: Rest of World Historic Review for HLA Typing for Transplant by Application - Diagnostics and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 135: Rest of World 15-Year Perspective for HLA Typing for Transplant by Application - Percentage Breakdown of Value Sales for Diagnostics and Research for the Years 2012, 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 41
Note: Product cover images may vary from those shown
Adroll
adroll